Post hepatectomy liver failure (PHLF)–recent advances in prevention and clinical management
JA Søreide, R Deshpande - European Journal of Surgical Oncology, 2021 - Elsevier
Background Posthepatectomy liver failure (PHLF) is a relatively rare but feared complication
following liver surgery, and associated with high morbidity, mortality and cost implications …
following liver surgery, and associated with high morbidity, mortality and cost implications …
[HTML][HTML] Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
Background & Aims Resection is the most widely used potentially curative treatment for
patients with early hepatocellular carcinoma (HCC). However, recurrence within 2 years …
patients with early hepatocellular carcinoma (HCC). However, recurrence within 2 years …
Clinical application of Albumin-Bilirubin (ALBI) score: The current status
M Deng, SWY Ng, ST Cheung, CCN Chong - The Surgeon, 2020 - Elsevier
Prognosis of patients that have undergone liver resection can be predicted preoperatively.
Albumin-Bilirubin (ALBI) is a useful score to evaluate liver function objectively. This score is …
Albumin-Bilirubin (ALBI) is a useful score to evaluate liver function objectively. This score is …
Albumin-bilirubin (ALBI) grade as part of the evidence-based clinical practice guideline for HCC of the Japan Society of Hepatology: a comparison with the liver …
A Hiraoka, T Kumada, M Kudo, M Hirooka, K Tsuji… - Liver cancer, 2017 - karger.com
Abstract Aim/Background: The purpose of this study was to evaluate the validity of 3
classifications for assessing liver function, the liver damage and Child-Pugh classifications …
classifications for assessing liver function, the liver damage and Child-Pugh classifications …
Nivolumab in patients with advanced hepatocellular carcinoma and Child‐Pugh class B cirrhosis: safety and clinical outcomes in a retrospective case series
S Kambhampati, KE Bauer, PM Bracci, BP Keenan… - Cancer, 2019 - Wiley Online Library
Background Nivolumab demonstrated durable responses and safety in patients with
hepatocellular carcinoma (HCC) with Child‐Pugh class A cirrhosis in the CheckMate 040 …
hepatocellular carcinoma (HCC) with Child‐Pugh class A cirrhosis in the CheckMate 040 …
A comparative study of albumin-bilirubin score with Child-Pugh score, model for end-stage liver disease score and indocyanine green R15 in predicting …
H Zou, X Yang, QL Li, QX Zhou, L Xiong, Y Wen - Digestive diseases, 2018 - karger.com
Background: The albumin-bilirubin (ALBI) grade is a newly proposed model for assessing
the hepatic function. This study aimed to compare the value of the ALBI score with Child …
the hepatic function. This study aimed to compare the value of the ALBI score with Child …
Usefulness of albumin‐bilirubin grade for evaluation of long‐term prognosis for hepatitis B‐related cirrhosis
RC Chen, YJ Cai, JM Wu, XD Wang… - Journal of viral …, 2017 - Wiley Online Library
Long‐term prognosis varies widely among patients with hepatitis B virus (HBV)‐related liver
cirrhosis. Our study aimed to investigate the applicability of albumin‐bilirubin (ALBI), Child …
cirrhosis. Our study aimed to investigate the applicability of albumin‐bilirubin (ALBI), Child …
Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure
B Chen, S Lin - Medicine, 2017 - journals.lww.com
The albumin-bilirubin (ALBI) score is a new model for assessing the severity of liver
dysfunction. The purpose of the present study is to investigate the prognostic value of the …
dysfunction. The purpose of the present study is to investigate the prognostic value of the …
Assessment of prognostic performance of Albumin–Bilirubin, Child–Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated …
SA Xavier, R Vilas-Boas, PB Carvalho… - European journal of …, 2018 - journals.lww.com
Objective The Albumin–Bilirubin (ALBI) score was developed recently to assess the severity
of liver dysfunction. We aimed to assess its prognostic performance in patients with liver …
of liver dysfunction. We aimed to assess its prognostic performance in patients with liver …
Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion
Background: Transarterial chemo-embolisation (TACE) is recommended for patients with
BCLC intermediate stage hepatocellular carcinoma (stage B), particularly in patients with …
BCLC intermediate stage hepatocellular carcinoma (stage B), particularly in patients with …